Stay updated with breaking news from Global Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Strengthened Clinical and Regulatory Leadership Team with Key AppointmentsStart-up Activities for the Global Phase 3 Trial Ongoing with Release of Drug Product Manufactured with Commercial Process and First Patient Expected to be Dosed in 2H 2023BOSTON--(BUSINESS WIRE)--Aura Biosciences Inc. (NASDAQ: AURA), a clinic...
LIVMARLI First and Only Treatment Approved in Mainland China for Cholestatic Pruritus in ALGS CANbridge to Hold Investor CallBEIJING & BURLINGTON, Mass. ...
- Eight Presentations on Yescarta and TecartusAdvance Kite's Cell Therapy Leadership - - New Data Highlight Magrolimab's Potential to Alter the Tumor Microenvironment - Gilead Sciences, Inc. (Nasdaq:
– Eight Presentations on Yescarta® and Tecartus® Advance Kite’s Cell Therapy Leadership – – New Data Highlight Magrolimab’s Potential to Alter the Tumor... | June 1, 2023
An FDA panel strongly endorsed Thursday that it could be the first maternal respiratory syncytial virus (RSV) vaccine approved to protect infants from the annual epidemic. All 14 members of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to conclude that the available data suggest that Pfizer’s RSV prefusion F administered […]